Overview

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis

Status:
Completed

Trial end date:
2016-12-28

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if treatment with romosozumab is effective in preventing fractures in women with postmenopausal osteoporosis

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Denosumab